Clinical Research Directory
Browse clinical research sites, groups, and studies.
CIRSE Registry for LifePearl Microspheres
Sponsor: Cardiovascular and Interventional Radiological Society of Europe
Summary
The application of transarterial chemoembolisation (TACE) using LifePearl Microspheres loaded with Irinotecan in liver-only or liver-dominant metastatic disease in patients with colorectal adenocarcinoma will be observed. The registry has the following objectives: 1. map the exact indications that the device is being used for and at which stage in treatment it is being applied 2. to assess observed treatment outcomes in terms of safety and effectiveness as well as trying to determine any predictive response factors
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
152
Start Date
2018-02-02
Completion Date
2022-04-30
Last Updated
2026-05-13
Healthy Volunteers
No
Conditions
Interventions
LifePearl Microspheres loaded with Irinotecan
LifePearl Microspheres are embolisation microspheres for transcatheter chemoembolisation (TACE), that can be loaded with chemotherapeutic agents. In this registry, LifePearl Microspheres will be loaded with Irinotecan.
Locations (1)
CIRSE Cardiovascular and Interventional Radiological Society of Europe
Vienna, State of Vienna, Austria